Information Provided By: 
Fly News Breaks for February 7, 2018
HAE
Feb 7, 2018 | 08:57 EDT
JMP Securities analyst David Turkaly noted that Haemonetics' Q3 sales and EPS beat expectations. The company's gross margin was "strong" and he thinks it should get stronger, he tells investors. Turkaly raised his price target on the shares to $72 following the report and maintains an Outperform rating on Haemonetics.
News For HAE From the Last 2 Days
There are no results for your query HAE
